---
title: Aurobindo Pharma CDMO vs Sai Life Sciences
slug_a: aurobindo
slug_b: sailife
site: cdmo
review_signal_gate: closed
canonical_path: /compare/aurobindo/sailife
---

# Aurobindo Pharma CDMO vs Sai Life Sciences

Side-by-side profile data from each company listing on this directory.

## Aurobindo Pharma CDMO

- Profile: [/companies/aurobindo](/companies/aurobindo)

Aurobindo Pharma CDMO — Aurobindo Pharma Limited is one of the largest generic pharmaceutical companies globally, with a strong commitment to making medicines affordable and accessible.

Services: 6. Modalities: 2. Indications: 2. Locations: 3. Certifications: 0. The strongest documented coverage currently appears in services (6).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- Biologics Development & Manufacturing
- Recombinant Protein Manufacturing
- Quality Control Testing
- Stability Testing & Storage

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Max chemical: Commercial (>100 kg / tonne)

## Sai Life Sciences

- Profile: [/companies/sailife](/companies/sailife)

Sai Life Sciences — Integrated CRDMO offering discovery, development, and manufacturing services for small molecule NCE programs across 280+ global pharma and biotech clients.

Services: 13. Modalities: 2. Indications: 0. Locations: 12. Certifications: 7. The strongest documented coverage currently appears in services (13).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- Flow Chemistry & Continuous Manufacturing
- Solid-State Chemistry & Polymorph Screening
- ADC (Antibody-Drug Conjugate) Manufacturing
- ADC Payload & Linker Synthesis
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Antibody-Drug Conjugate (ADC)

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing
- Solid-state characterization

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Max chemical: Commercial (>100 kg / tonne)
- Flow Chemistry
- Cryogenic (−80 °C)